Compare Edwards Lifesciences Corporation Common Stock (EW) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Nano Dimension Ltd - ADR — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.1 (market cap $48.56B), while Nano Dimension Ltd - ADR trades at $1.58 (market cap $328.52M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 147.8× Nano Dimension Ltd - ADR's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| EW | NNDM | |
|---|---|---|
Market Cap | $48.56B | $328.52M |
Volume | 6,520,488 | 1,160,945 |
Sector | Health | Technology |
52-Week High | $95.18 | $2.14 |
52-Week Low | $72.65 | $1.21 |
Enterprise Value | $45.01B | -$76.33M |
Typical Hold Time | — | 43 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NNDM trades at $1.55, down 1.27% with bearish technical signals. The company shows revenue growth from $102M in 2025 to $121M in 2026 but continues to post significant losses with a -135.18% net income margin. Recent strategic moves include cost-cutting initiatives and leadership changes aimed at reducing cash burn. The stock faces headwinds from negative cash flow trends and persistent unprofitability despite improving sales.
Outlook remains challenging with substantial execution risks. The company's cash position of $758M provides runway, but continued losses and negative operating cash flow pose sustainability concerns. Investment opportunity exists if cost reductions translate to profitability, but high risk profile requires careful monitoring of quarterly execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
